日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Decompensated Liver Cirrhosis Research Network (UK-CLIF): Building consensus for hepatology trials in the UK

英国失代偿性肝硬化研究网络(UK-CLIF):为英国肝病学试验建立共识

Crisp, Helen; Tavabie, Oliver; Enever, Yvanne; Allen, Richard; Silverman, Milton; Acevedo, Juan; Chauhan, Abhishek; Hogan, Brian; Patel, Vishal; Mookerjee, Rajeshwar; Wright, Gavin; Aspinall, Richard; McPherson, Stuart; Cook, Andrew; Jalan, Rajiv; Mehta, Gautam

Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511]

对“在英国接种两剂 ChAdOx1 nCov-19 或 BNT162b2 后,作为第三剂加强针接种的七剂 COVID-19 疫苗的免疫原性持久性:COV-BOOST 试验的三个月分析”的更正 [J Infect 84(6) (2022) 795-813, 5511]

Liu, Xinxue; Munro, Alasdair Ps; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

英国异源和同源新冠疫苗第三剂接种方案后免疫反应的持久性:COV-BOOST试验的八个月分析

Liu, Xinxue; Munro, Alasdair P S; Wright, Annie; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baker, Jonathan; Baxter, David; Bawa, Tanveer; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Fox, Lauren; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Haughney, John; Hicks, Alexander; Jones, Christine E; Kanji, Nasir; van der Klaauw, Agatha A; Libri, Vincenzo; Llewelyn, Martin J; Mansfield, Rebecca; Maallah, Mina; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Belhadef, Hanane Trari; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Stokes, Matthew; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

在接种两剂 ChAdOx1 nCoV-19 或 BNT162b2 疫苗后,再接种第三剂 BNT162b2 疫苗(COV-BOOST),评估 BNT162b2 和 mRNA-1273 COVID-19 疫苗作为第四剂加强针的安全性、免疫原性和反应原性:一项多中心、双盲、II 期随机试验

Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kanji, Nasir; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Maallah, Mina; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Bawa, Tanveer; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Liu, Xinxue; Faust, Saul N

Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial

在英国,接种两剂 ChAdOx1 nCov-19 或 BNT162b2 疫苗后,再接种第三剂 COVID-19 疫苗,七例患者接种后免疫原性持久性:COV-BOOST 试验的三个月分析

Liu, Xinxue; Munro, Alasdair P S; Feng, Shuo; Janani, Leila; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dejnirattisai, Wanwisa; Dodd, Kate; Enever, Yvanne; Qureshi, Ehsaan; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Holliday, Kyra; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Serafimova, Teona; Saralaya, Dinesh; Screaton, Gavin R; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Supasa, Piyada; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Lambe, Teresa; Nguyen-Van-Tam, Jonathan S; Cornelius, Victoria; Snape, Matthew D; Faust, Saul N

The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity

基于VH的多特异性人源化抗体CB213可同时靶向T细胞上的PD1和LAG3,从而促进抗肿瘤活性。

Carolyn J Edwards ,Angelica Sette ,Carl Cox ,Barbara Di Fiore ,Chris Wyre ,Daniela Sydoruk ,David Yadin ,Philip Hayes ,Szymon Stelter ,Phillip D Bartlett ,Miren Zuazo ,Maria Jesus Garcia-Granda ,Giovanni Benedetti ,Stratoniki Fiaska ,Neil R Birkett ,Yumin Teng ,Carrie Enever ,Hugo Arasanz ,Ana Bocanegra ,Luisa Chocarro ,Gonzalo Fernandez ,Ruth Vera ,Bethan Archer ,Isabelle Osuch ,Martyna Lewandowska ,Yasmin M Surani ,Grazyna Kochan # ,David Escors # ,James Legg ,Andrew J Pierce

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

在英国开展的一项名为“COV-BOOST”的研究,旨在评估七种新冠疫苗作为第三剂(加强剂)在接种两剂 ChAdOx1 nCov-19 或 BNT162b2 疫苗后的安全性和免疫原性:一项双盲、多中心、随机、对照的 II 期临床试验。

Munro, Alasdair P S; Janani, Leila; Cornelius, Victoria; Aley, Parvinder K; Babbage, Gavin; Baxter, David; Bula, Marcin; Cathie, Katrina; Chatterjee, Krishna; Dodd, Kate; Enever, Yvanne; Gokani, Karishma; Goodman, Anna L; Green, Christopher A; Harndahl, Linda; Haughney, John; Hicks, Alexander; van der Klaauw, Agatha A; Kwok, Jonathan; Lambe, Teresa; Libri, Vincenzo; Llewelyn, Martin J; McGregor, Alastair C; Minassian, Angela M; Moore, Patrick; Mughal, Mehmood; Mujadidi, Yama F; Murira, Jennifer; Osanlou, Orod; Osanlou, Rostam; Owens, Daniel R; Pacurar, Mihaela; Palfreeman, Adrian; Pan, Daniel; Rampling, Tommy; Regan, Karen; Saich, Stephen; Salkeld, Jo; Saralaya, Dinesh; Sharma, Sunil; Sheridan, Ray; Sturdy, Ann; Thomson, Emma C; Todd, Shirley; Twelves, Chris; Read, Robert C; Charlton, Sue; Hallis, Bassam; Ramsay, Mary; Andrews, Nick; Nguyen-Van-Tam, Jonathan S; Snape, Matthew D; Liu, Xinxue; Faust, Saul N

TELO-SCOPE study: a randomised, double-blind, placebo-controlled, phase 2 trial of danazol for short telomere related pulmonary fibrosis

TELO-SCOPE 研究:一项随机、双盲、安慰剂对照的 II 期临床试验,研究达那唑治疗短端粒相关性肺纤维化的疗效

Mackintosh, John A; Pietsch, Maria; Lutzky, Viviana; Enever, Debra; Bancroft, Sandra; Apte, Simon H; Tan, Maxine; Yerkovich, Stephanie T; Dickinson, Joanne L; Pickett, Hilda A; Selvadurai, Hiran; Grainge, Christopher; Goh, Nicole S; Hopkins, Peter; Glaspole, Ian; Reynolds, Paul N; Wrobel, Jeremy; Jaffe, Adam; Corte, Tamera J; Chambers, Daniel C

Mesenchymal Stromal Cell Therapy for Chronic Lung Allograft Dysfunction: Results of a First-in-Man Study

间充质干细胞疗法治疗慢性肺移植功能障碍:首例人体试验结果

Chambers, Daniel C; Enever, Debra; Lawrence, Sharon; Sturm, Marian J; Herrmann, Richard; Yerkovich, Stephanie; Musk, Michael; Hopkins, Peter M A

Disease-associated prion protein elicits immunoglobulin M responses in vivo

与疾病相关的朊病毒蛋白在体内引发免疫球蛋白 M 反应

Mourad Tayebi, Perry Enever, Zahid Sattar, John Collinge, Simon Hawke